Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans

Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans

OBJECTIVE— Fibroblast growth factor 21 (FGF21) is a metabolic regulator with multiple beneficial effects on glucose homeostasis and insulin sensitivity in animal models. This study aimed to investigate the relationship between its serum levels and various cardiometabolic parameters in humans. RESEAR...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinmei Zhang, Dennis C.Y. Yeung, Michal Karpíšek, David Stejskal, Zhiguang Zhou, Feng Liu, Rachel L.C. Wong, Wing‐Sun Chow, Annette W.K. Tso, Karen S.L. Lam, Aimin Xu
Format: Artigo
Language:English
Published: 2008
Online Access:https://doi.org/10.2337/db07-1476
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.2337/db07-1476

Similar Items